Postal Ballot Results: Three Director Appointments Approved

Board & Shareholder Meetings View source PDF

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.4%1-day move

₹638.50

prior close

₹617.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.5+1.3+1.2+1.3-0.4-1.2+2.7-3.7-2.6+4.0+10.4+7.4+49.9+32.7

Up moveDown movePending

AI summary

Supriya Lifescience announced postal ballot results for three special resolutions, all passed with over 99.85% approval. Resolutions include: appointment of Mr. Manish Panchal and Mr. Kothandaraman Hari as Non-Executive Independent Directors (5-year terms from Feb 9, 2026), and re-appointment of Dr. Neelam Arora for a second 5-year term from March 25, 2026. Of 83,037 shareholders, 222 participated, with 5.83 crore shares voted (72.47% of outstanding shares). Dissent was minimal at under 0.15% on each resolution.

Likely market impact

Board independence strengthened with three independent director appointments; routine governance matter with no material business impact.